1Archer DB.Diabetic retinopathy:some cellular,molecular and therapeutic considerations[J].Eye.1999,13:497～523
2Clements RS Jr,Robison WG Jr,Cohen MP.Anti-g1ycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice [J].J Diabetes Comp.1998,12:28～33
3Giulio Romeo,Wei-Hua Liu,Veronica Asnaghi,et al.activation of nuclear factor-κB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes[J].diabetes.2002,51:2241～2248
4Aso Y,Inukai T,Tayama K,et al.Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes [J].Acta Diabetol.2000,37(2):87～92
5Stitt AW,Vlassara H.Advanced glycation endproducts:impact on diabetic complications.In:Betteridge DJ,ed.Current perspectives in diabetes[M].London:Martin Dunitz.1999,67～92
6Imanaga Y,Sakata N,Takebayashi S,et al.In vivo and in vivtro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques[J].Atherosclerosis.2000,150(2) :343～355
7Stitt AW,Bhaduri T,McMullen CBT,et al.Advanced glycation endproducts cause breakdown of the blood retinal barrier in normoglycaemic rats:implications for barrier discruption during diabetic retinopathy[J].Mol Cell Biol Res Commun.2000,3:380～388
8Charlene E,Frederick M,Kymberly A,et al.Thrombomodulin Deficiency in Human Diabetic Nerve Microvasculature[J] .Diabetes.2002,51:1957～1963
9Hasegawa Y,Suehiro A,Higasa S,et al.Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus[J].Thromb Res.2002,107(6) :319～323
10Vlassara H.The AGE-receptor in the pathogenesis of diabetic complications[J].Diabetes Metab Res Rev.2001,17(6) :436～443
